INGN logo

Inogen (INGN)

Profile

Full Name

Inogen, Inc.

Ticker Symbol

INGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

February 14, 2014

Indexes

Not included

Website

http://www.inogen.com

Employees

766

Key Details

Price

$7.26(-0.68%)

Market cap

$192.60M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$335.70M(+6.35% YoY)

Annual EPS

-$1.52(+65.61% YoY)

PE ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.26
INGN price is $7.26

30-Day Relative Volume

0.83
INGN 30-day relative volume is 0.83

Price Performance

Price Today change

-0.68%
INGN price is down -0.68% today

Price YTD change

-20.83%
INGN price is down -20.83% since January 1st

Price 1-year change

-1.36%
INGN price is down -1.36% year-on-year

Price 3-year change

-74.39%
INGN price is down -74.39% over the past 3 years

Price Range

Price All-time high

$287.79
INGN price is currently -97.48% below its historical high of $287.79

Price 3-year low

$4.13
INGN price is currently +75.79% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$192.60M
INGN market capitalization is $192.60 million

Market cap 3-year change

-70.25%
INGN market capitalization is down -70.25% over the past 3 years

Market cap All-time high

$6.04B
INGN market capitalization is currently -96.81% below its historical high of $6.04 billion

Market cap sector rank

56.78%
INGN market capitalization is higher than 56.78% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+12.67%
INGN shares outstanding is up +12.67% year-on-year

Shares Outstanding 3-Year Change

+16.18%
INGN shares outstanding is up +16.18% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.91
INGN beta is 0.91

200-day SMA

$9.62
INGN price is currently -24.51% below its 200-day simple moving average

50-day SMA

$8.55
INGN price is currently -15.04% below its 50-day simple moving average

RSI

46.40
INGN 14-day relative strength index is 46.40

Volume

0.83
INGN 30-day relative volume is 0.83

ATR

$0.51
INGN average true range is $0.51

10-day Historical Volatility

64.48%
INGN 10-day historical volatility is 64.48%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$335.70M
INGN annual revenue is $335.70 million

Revenue Analysts estimate

$352.88M
INGN annual revenue is currently -4.87% lower than the consensus analysts' forecast

Revenue 1-year change

+6.35%
INGN annual revenue is up +6.35% year-on-year

Revenue Sector rank

70.1%
INGN annual revenue is higher than 70.1% of companies in Healthcare sector

EPS

EPS

-$1.52
INGN annual earnings per share is -$1.52

EPS Analysts estimate

-$0.69
INGN annual earnings per share is currently +118.71% higher than the consensus analysts' forecast

EPS 1-year change

+65.61%
INGN annual earnings per share is up +65.61% year-on-year

EPS Sector rank

45.5%
INGN annual earnings per share is higher than 45.5% of companies in Healthcare sector

Profit

Gross profit

$154.74M
INGN annual gross profit is $154.74 million

Gross margin

46.09%
INGN annual gross profit margin is 46.09%

Operating profit

-$42.52M
INGN annual operating income is -$42.52 million

Operating margin

-12.66%
INGN annual operating profit margin is -12.66%

Net income

-$35.89M
INGN annual net profit is -$35.89 million

Net margin

-10.69%
INGN annual net profit margin is -10.69%

Expenses

Total expenses

$378.22M
INGN annual total expenses is $378.22 million

Operating expenses

$197.26M
INGN annual total operating expenses is $197.26 million

Cost of goods sold

$180.96M
INGN annual cost of goods sold is $180.96 million

Selling, general & administrative expenses

$175.65M
INGN annual SGA is $175.65 million

Depreciation and amortization

$21.00M
INGN annual depreciation & amortization is $21.00 million

Interest expense

-
INGN annual interest expense value is unknown

Income tax

-$588.00K
INGN annual income tax is -$588.00 thousand

EBIT & EBITDA

EBIT

-$42.52M
INGN annual earnings before interest & taxes is -$42.52 million

EBITDA

-$21.51M
INGN annual EBITDA is -$21.51 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$296.19M
INGN annual total assets is $296.19 million

Non current assets

$110.73M
INGN annual long term assets is $110.73 million

Current assets

$185.45M
INGN annual total current assets is $185.45 million

Cash and cash equivalents

$113.80M
INGN annual cash & cash equivalents is $113.80 million

Accounts receivable

$29.56M
INGN annual accounts receivable is $29.56 million

Inventory

$24.81M
INGN annual inventory is $24.81 million

Liabilities

Total liabilities

$122.33M
INGN annual total liabilities is $122.33 million

Long term liabilities

$45.64M
INGN annual total long term liabilities is $45.64 million

Current liabilities

$76.69M
INGN annual total current liabilities is $76.69 million

Accounts payable

$27.15M
INGN annual accounts payable is $27.15 million

Debt

Total debt

$19.41M
INGN annual total debt is $19.41 million

Total debt 1-year change

-11.48%
INGN annual total debt is down -11.48% year-on-year

Long term debt

$16.59M
INGN annual long term debt is $16.59 million

Short term debt

$2.81M
INGN annual short term debt is $2.81 million

Equity & Capital

Shareholders equity

$173.86M
INGN annual stockholders equity is $173.86 million

Book value

$173.86M
INGN annual book value is $173.86 million

Retained earnings

-$152.84M
INGN annual retained earnings is -$152.84 million

Working capital

$108.77M
INGN annual working capital is $108.77 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$5.91M
INGN annual cash flow from operations is $5.91 million

Cash from operations 1-year change

+282.87%
INGN annual cash flow from operations is up +282.87% year-on-year

Cash from investing

-$13.97M
INGN annual cash flow from investing activities is -$13.97 million

Cash from investing 1-year change

+76.44%
INGN annual cash flow from investing activities is up +76.44% year-on-year

Cash from financing

$265.00K
INGN annual cash flow from financing activities is $265.00 thousand

Cash from financing 1-year change

-72.4%
INGN annual cash flow from financing activities is down -72.4% year-on-year

CAPEX

CAPEX

$17.09M
INGN annual capital expenditures is $17.09 million

CAPEX 1-year change

-36.72%
INGN annual capital expenditures is down -36.72% year-on-year

Free Cash Flow

Free cash flow

-$11.18M
INGN annual free cash flow is -$11.18 million

Free cash flow 1-year change

+63.04%
INGN annual free cash flow is up +63.04% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

46.09%
INGN annual gross profit margin is 46.09%

Operating margin

-12.66%
INGN annual operating profit margin is -12.66%

Net margin

-10.69%
INGN annual net profit margin is -10.69%

ROA & ROE

ROA

-11.53%
INGN annual return on assets is -11.53%

ROE

-18.95%
INGN annual return on equity is -18.95%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
INGN price to earnings ratio value is unknown

PE ratio Sector rank

-
INGN price to earnings ratio is unknown

PB Ratio

PB ratio

1.11
INGN price to book ratio is 1.11

PB ratio Sector rank

46.46%
INGN price to book ratio is higher than 46.46% of companies in Healthcare sector

PS Ratio

PS ratio

0.57
INGN price to sales ratio is 0.57

PS ratio Sector rank

18.72%
INGN price to sales ratio is higher than 18.72% of companies in Healthcare sector

Enterprise value

Enterprise value

$98.22M
INGN enterprise value is $98.22 million

Enterprise value Sector rank

50.21%
INGN enterprise value is higher than 50.21% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-4.57
INGN EV/EBITDA is -4.57

EV/EBITDA Sector rank

19.46%
INGN EV/EBITDA is higher than 19.46% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.42
INGN annual current ratio is 2.42

Quick ratio

2.09
INGN annual quick ratio is 2.09

Leverage

Debt to equity

0.00
INGN annual debt to equity ratio is 0.00

Interest coverage ratio

-
INGN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

5
INGN piotroski f-score is 5

Altman Z-Score

1.32
INGN altman z-score is 1.32

Analyst ratings

Recent major analysts updates

Apr 9, 25 Needham
Hold
Feb 27, 25 Needham
Hold
Feb 26, 25 Needham
Hold
Jan 30, 25 Needham
Hold
Jan 14, 25 Needham
Hold
Nov 8, 24 Needham
Hold
Aug 7, 24 Needham
Hold
May 8, 24 Stifel
Hold
May 8, 24 Needham
Hold
Apr 9, 24 Needham
Hold

Institutional Ownership

Similar stocks

NVCT logo
Nuvectis Pharma (NVCT)
ANIK logo
Anika Therapeutics (ANIK)
CDXS logo
Codexis (CDXS)
ELMD logo
Electromed (ELMD)
AMRN logo
Amarin (AMRN)
SOPH logo
SOPHiA GENETICS SA (SOPH)
FHTX logo
Foghorn Therapeutics (FHTX)
CARGO Therapeutics (CRGX)
Zhengye Biotechnology Holding Limited (ZYBT)
  • What is the ticker symbol for Inogen?
  • Does Inogen pay dividends?
  • What sector is Inogen in?
  • What industry is Inogen in?
  • What country is Inogen based in?
  • When did Inogen go public?
  • Is Inogen in the S&P 500?
  • Is Inogen in the NASDAQ 100?
  • Is Inogen in the Dow Jones?
  • When was Inogen's last earnings report?
  • When does Inogen report earnings?
  • Should I buy Inogen stock now?

What is the ticker symbol for Inogen?

The ticker symbol for Inogen is NASDAQ:INGN

Does Inogen pay dividends?

No, Inogen does not pay dividends

What sector is Inogen in?

Inogen is in the Healthcare sector

What industry is Inogen in?

Inogen is in the Medical Devices industry

What country is Inogen based in?

Inogen is headquartered in United States

When did Inogen go public?

Inogen's initial public offering (IPO) was on February 14, 2014

Is Inogen in the S&P 500?

No, Inogen is not included in the S&P 500 index

Is Inogen in the NASDAQ 100?

No, Inogen is not included in the NASDAQ 100 index

Is Inogen in the Dow Jones?

No, Inogen is not included in the Dow Jones index

When was Inogen's last earnings report?

Inogen's most recent earnings report was on Feb 25, 2025

When does Inogen report earnings?

The next expected earnings date for Inogen is May 7, 2025

Should I buy Inogen stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page